Finzati - Logo
ALZN logo

Alzamend Neuro Inc

ALZNBiotechnology
$1.66
-0.04 (-2.35%)
Current price
EarningsLatest report: Apr 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.96M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 1.31Weak profitability
Financial data as of: Apr 30, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.66
Change-2.35%
Market Cap$3.96M
52W Range0.84 - 3.01
Beta0.14
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1.31
Quick Ratio1.31
Volume34.72K

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
84/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
60/100
Why this score
Manageable debt level · 0Healthy liquidity · 1.31Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/15/2021
Industry: Biotechnology
P/B i: 5.19
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.00
Current Ratio: 1.31
Quick Ratio: 1.31
Status: Strong

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
AULT MILTON C III
Transaction: 04/14/2026
BUY
Change
+108,388
Price
$1.00
Filing
04/16/2026
Type
BUY
AULT MILTON C III
Transaction: 12/23/2025
SELL
Change
-1,851
Price
$2.07
Filing
12/30/2025
Type
SELL
Horne William B.
Transaction: 12/19/2025
SELL
Change
-3,333
Price
$2.12
Filing
12/23/2025
Type
SELL